Content

Welcome to the CJU website » LOG IN

Supplement - Feb 2005 ( Volume 12 )

  1. Supplement
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 1 - 1)
  1. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC)
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 2 - 6)
  1. Screening for prostate cancer: updated experience from the Tyrol study
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 7 - 13)
  1. Defining high-risk prostate cancer: current status
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 14 - 17)
  1. Penile cancer: current challenges
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 18 - 23)
  1. Sentinel lymph node biopsy in penile cancer: evolution and insights
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 24 - 29)
  1. Extended lymphadenectomy in penile cancer
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 30 - 36)
  1. Open retroperitoneal lymph node dissection
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 37 - 39)
  1. UPM3: review of a new molecular diagnostic urine test for prostate cancer
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 40 - 43)
  1. Prostate biopsy: who, how and when. An update
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 44 - 48)
  1. Prostatic intraepithelial neoplasia: a risk factor for prostate cancer
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 49 - 52)
  1. Active surveillance with selective delayed intervention: walking the line between overtreatment for indolent disease and undertreatment for aggressive
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 53 - 57)
  1. Surgery or radiation: what is the optimal management for locally advanced prostate cancer?
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 58 - 61)
  1. Stage I nonseminomatous germ cell tumors: the case for management by risk stratification
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 62 - 65)
  1. New treatments for metastatic kidney cancer
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 66 - 70)
  1. Bone loss in prostate cancer: evaluation, treatment and prevention
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 71 - 76)
  1. Effectiveness of Maximal Androgen Blockade (MAB): illusion or reality?
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 77 - 80)
  1. Recent docetaxel studies establish a new standard of care in hormone refractory prostate cancer
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 81 - 85)
  1. International regional working groups on prostate cancer: results of consensus development.
    The Canadian Journal of Urology
    Feb 2005 (Volume 12, Pages 86 - 91)